In the United States Court of Federal Claims
                                 OFFICE OF SPECIAL MASTERS
                                          No. 14-322V
                                       Filed: May 9, 2017
                                       Not to be Published

*************************************
BERENICE DORRIS,                              *
                                              *
               Petitioner,                    *    Joint stipulation of dismissal;
                                              *    Order Concluding Proceedings
 v.                                           *    under Vaccine Rule 21(a)(1)(B);
                                              *    tetanus-diphtheria-acellular pertussis
SECRETARY OF HEALTH                           *    (“Tdap”) vaccine; Type 1 diabetes.
AND HUMAN SERVICES,                           *
                                              *
               Respondent.                    *
                                              *
*************************************
Jeffrey S. Pop, Beverly Hills, CA, for petitioner.
Jason C. Bougere, Washington, DC, for respondent.

MILLMAN, Special Master

                            ORDER CONCLUDING PROCEEDINGS 1

       On April 21, 2014, petitioner filed a petition under the National Childhood Vaccine
Injury Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that tetanus-diphtheria-acellular pertussis
(“Tdap”) vaccine administered on March 1, 2012 caused her Type 1 diabetes. See Pet. Preamble
and ¶ 10.

       On May 8, 2017, petitioner filed a Joint Stipulation of Dismissal under Vaccine Rule
21(a)(1)(B).


1
  Because this Order Concluding Proceedings contains a reasoned explanation for the special master’s
action in this case, the special master intends to post this Order Concluding Proceedings on the United
States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, 44 U.S.C. §
3501 note (2012) (Federal Management and Promotion of Electronic Government Services). Vaccine
Rule 18(b) states that all decisions of the special masters will be made available to the public unless they
contain trade secrets or commercial or financial information that is privileged and confidential, or medical
or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy.
When such a decision is filed, petitioners have 14 days to identify and move to redact such information
prior to the document’s disclosure. If the special master, upon review, agrees that the identified material
fits within the categories listed above, the special master shall redact such material from public access.
                                        DISCUSSION

       Under Vaccine Rule 21(a)(1)(B), petitioner may voluntarily dismiss the petition without
order of the special master by filing a stipulation of dismissal signed by all parties who have
appeared in the action. Petitioner has done this in this case.

       Under Vaccine Rule 21(a)(3), the result of this voluntary dismissal is an Order
Concluding Proceedings. No judgment will enter pursuant to Vaccine Rule 11 for purposes of
42 U.S.C. § 300aa-21(a).

                                       CONCLUSION

        This petition is DISMISSED. The clerk of the court is directed to remove this case from
the docket of the undersigned.


IT IS SO ORDERED.


Dated: May 9, 2017                                                  s/ Laura D. Millman
                                                                     Laura D. Millman
                                                                       Special Master




                                               2
